BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1712 related articles for article (PubMed ID: 30408744)

  • 41. Derivation and characterization of induced pluripotent stem cells from equine fibroblasts.
    Breton A; Sharma R; Diaz AC; Parham AG; Graham A; Neil C; Whitelaw CB; Milne E; Donadeu FX
    Stem Cells Dev; 2013 Feb; 22(4):611-21. PubMed ID: 22897112
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Generation of two induced pluripotent stem cell lines from a patient with Stargardt Macular Dystrophy caused by the c.768G>T and c.6079C>T mutations in ABCA4.
    Jennings L; Zhang D; Chen SC; Moon SY; Lamey T; Thompson JA; McLaren T; De Roach JN; Chen FK; McLenachan S
    Stem Cell Res; 2020 Oct; 48():101947. PubMed ID: 32810830
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Generation of two induced pluripotent stem cell (iPSC) lines from human breast milk using episomal reprogramming system.
    Tang C; Lu C; Ji X; Ma L; Zhou Q; Xiong M; Zhou W
    Stem Cell Res; 2019 Aug; 39():101511. PubMed ID: 31404746
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Generation of Integration-free Induced Pluripotent Stem Cells from Human Peripheral Blood Mononuclear Cells Using Episomal Vectors.
    Wen W; Zhang JP; Chen W; Arakaki C; Li X; Baylink D; Botimer GD; Xu J; Yuan W; Cheng T; Zhang XB
    J Vis Exp; 2017 Jan; (119):. PubMed ID: 28117800
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Generation of human induced pluripotent stem cell line UNIGEi001-A from a 2-years old patient with Mucopolysaccharidosis type IH disease.
    Lito S; Burda P; Baumgartner M; Sloan-Béna F; Táncos Z; Kobolák J; Dinnyés A; Krause KH; Marteyn A
    Stem Cell Res; 2019 Dec; 41():101604. PubMed ID: 31678774
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Highly efficient induced pluripotent stem cell reprogramming of cryopreserved lymphoblastoid cell lines.
    Kumar S; Curran JE; Espinosa EC; Glahn DC; Blangero J
    J Biol Methods; 2020; 7(1):e124. PubMed ID: 31976351
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Non-integrating episomal plasmid-based reprogramming of human amniotic fluid stem cells into induced pluripotent stem cells in chemically defined conditions.
    Slamecka J; Salimova L; McClellan S; van Kelle M; Kehl D; Laurini J; Cinelli P; Owen L; Hoerstrup SP; Weber B
    Cell Cycle; 2016; 15(2):234-49. PubMed ID: 26654216
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Macrophage enzyme and reduced inflammation drive brain correction of mucopolysaccharidosis IIIB by stem cell gene therapy.
    Holley RJ; Ellison SM; Fil D; O'Leary C; McDermott J; Senthivel N; Langford-Smith AWW; Wilkinson FL; D'Souza Z; Parker H; Liao A; Rowlston S; Gleitz HFE; Kan SH; Dickson PI; Bigger BW
    Brain; 2018 Jan; 141(1):99-116. PubMed ID: 29186350
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Generation of integration-free human induced pluripotent stem cells from a patient with sporadic Parkinson's disease.
    Lee Y; Jeong D; Ham S; Son J; Ko K
    Stem Cell Res; 2024 Jun; 77():103416. PubMed ID: 38615589
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Inducing pluripotency in somatic cells from the snow leopard (Panthera uncia), an endangered felid.
    Verma R; Holland MK; Temple-Smith P; Verma PJ
    Theriogenology; 2012 Jan; 77(1):220-8, 228.e1-2. PubMed ID: 22079579
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Generation of mouse induced pluripotent stem cells from different genetic backgrounds using Sleeping beauty transposon mediated gene transfer.
    Muenthaisong S; Ujhelly O; Polgar Z; Varga E; Ivics Z; Pirity MK; Dinnyes A
    Exp Cell Res; 2012 Nov; 318(19):2482-9. PubMed ID: 22846649
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Generation of two Alpha-I antitrypsin deficiency patient-derived induced pluripotent stem cell lines ISRM-AATD-iPSC-1 (HHUUKDi011-A) and ISRM-AATD-iPSC-2 (HHUUKDi012-A).
    Ncube A; Bewersdorf L; Spitzhorn LS; Loerch C; Bohndorf M; Graffmann N; May L; Amzou S; Fromme M; Wruck W; Strnad P; Adjaye J
    Stem Cell Res; 2023 Sep; 71():103171. PubMed ID: 37506509
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Establishment of transgene-free induced pluripotent stem cells reprogrammed from human stem cells of apical papilla for neural differentiation.
    Zou XY; Yang HY; Yu Z; Tan XB; Yan X; Huang GT
    Stem Cell Res Ther; 2012 Oct; 3(5):43. PubMed ID: 23095454
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Generation and characterization of two iPSC lines from human epicardium-derived cells.
    Paulitschek C; Schulze-Matz P; Hesse J; Schmidt T; Wruck W; Adjaye J; Schrader J
    Stem Cell Res; 2017 Apr; 20():50-53. PubMed ID: 28395740
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Improved behavior and neuropathology in the mouse model of Sanfilippo type IIIB disease after adeno-associated virus-mediated gene transfer in the striatum.
    Cressant A; Desmaris N; Verot L; Bréjot T; Froissart R; Vanier MT; Maire I; Heard JM
    J Neurosci; 2004 Nov; 24(45):10229-39. PubMed ID: 15537895
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Generation of 2 iPSC clones from a patient with DNAJC12 deficiency: DHMCi003-A and DHMCi003-B.
    Jung-Klawitter S; Wächter S; Hagedorn M; Ebersold J; Göhring G; Opladen T
    Stem Cell Res; 2019 Apr; 36():101402. PubMed ID: 30901742
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Insulin Receptor Antibody-α-N-Acetylglucosaminidase Fusion Protein Penetrates the Primate Blood-Brain Barrier and Reduces Glycosoaminoglycans in Sanfilippo Type B Fibroblasts.
    Boado RJ; Lu JZ; Hui EK; Lin H; Pardridge WM
    Mol Pharm; 2016 Apr; 13(4):1385-92. PubMed ID: 26910785
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Generation of induced pluripotent stem cell (iPSC) line from a 36-year-old Charcot-Marie-Tooth disease patient with GJB1 mutation (CMTX).
    Son D; Kang PJ; Yun W; You S
    Stem Cell Res; 2017 May; 21():9-12. PubMed ID: 28677541
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Impaired adipogenic capacity in induced pluripotent stem cells from lipodystrophic patients with BSCL2 mutations.
    Mori E; Fujikura J; Noguchi M; Nakao K; Matsubara M; Sone M; Taura D; Kusakabe T; Ebihara K; Tanaka T; Hosoda K; Takahashi K; Asaka I; Inagaki N; Nakao K
    Metabolism; 2016 Apr; 65(4):543-56. PubMed ID: 26975546
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Development, characterization, and hematopoietic differentiation of Griscelli syndrome type 2 induced pluripotent stem cells.
    Güney-Esken G; Erol ÖD; Pervin B; Gürhan Sevinç G; Önder T; Bilgiç E; Korkusuz P; Günel-Özcan A; Uçkan-Çetinkaya D; Aerts-Kaya F
    Stem Cell Res Ther; 2021 May; 12(1):287. PubMed ID: 33985578
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 86.